Comparison of the Effects of Low-Dose Midazolam, Magnesium Sulfate, Remifentanil and Low-Dose Etomidate on Prevention of Etomidate-Induced Myoclonus in Orthopedic Surgeries

Abbas Sedighinejad, Bahram Naderi Nabi, Mohammad Haghighi, Gelareh Biazar, Vali Imantalab, Siamak Rimaz, Zahra Zaridoost, Abbas Sedighinejad, Bahram Naderi Nabi, Mohammad Haghighi, Gelareh Biazar, Vali Imantalab, Siamak Rimaz, Zahra Zaridoost

Abstract

Background: Etomidate is a potent hypnotic agent with several desirable advantages such as providing a stable cardiovascular profile with minimal respiratory adverse effects and better hemodynamic stability compared with other induction agents. This drug is associated, however, with myoclonic movements which is characterized by a sudden, brief muscle contractions as a disturbing side-effect.

Objectives: The present study was designed to compare the effectiveness of low- dose midazolam, magnesium sulfate, remifentanil and low-dose etomidate to suppress etomidate-induced myoclonus in orthopedic surgery.

Patients and methods: A double-blind clinical trial study was conducted in an academic hospital from September 2014 to August 2015. Two hundred and eighty-four eligible patients, American society of anesthesiologists class I - II, scheduled for elective orthopedic surgery were randomly allocated into four equal groups (n = 71). They received premedication with intravenous low-dose midazolam 0.015 mg/kg, magnesium sulfate 30 mg/kg, remifentanil 1 μg/kg and low-dose etomidate 0.03 mg/kg two minutes before induction of anesthesia with 0.3 mg/kg intravenous etomidate. Then the incidence and intensity of myoclonus were evaluated on a scale of 0 - 3; 0 = no myoclonus; 1 = mild (movement at wrist); 2 = moderate (movement at arm only, elbow or shoulder); and 3 = severe, generalized response or movement in more than one extremity, within ninety seconds. Any adverse effect due to these premedication agents was recorded.

Results: The incidence and intensity of myoclonus were significantly lower in the low-dose etomidate group. The incidence rates of myoclonus were 51 (71.85%), 61 (85.9%), 30 (42.3%) and 41 (57.7%), and the percentages of patients who experienced grade III of myoclonus were 30 (58.8%), 32 (52.5%), 9 (30%) and 14 (34.1%) in the midazolam, magnesium sulfate, etomidate and remifentanil groups, respectively. The incidence and intensity of myoclonus were significantly lower in the low-dose etomidate group (P = 0.0001). No notable adverse effect was detected in our patients during the study period.

Conclusions: Intravenous etomidate 0.03 mg/kg prior to induction can effectively reduce the incidence and severity of myoclonus linked to etomidate.

Keywords: Etomidate; Magnesium Sulfate; Midazolam; Prevention, Myoclonus; Remifentanil.

References

    1. Luan HF, Zhao ZB, Feng JY, Cui JZ, Zhang XB, Zhu P, et al. Prevention of etomidate-induced myoclonus during anesthetic induction by pretreatment with dexmedetomidine. Braz J Med Biol Res. 2015;48(2):186–90. doi: 10.1590/1414-431X20144100.
    1. Zhao X, Bao R, Zhu J, Liu Z, Meng Y, Fan X, et al. Pretreatment with butorphanol reduces myoclonus after etomidate. J Anesthesiol Clin Sci. 2013;2(1):2. doi: 10.7243/2049-9752-2-2.
    1. Soleimanpour H, Safari S, Rahmani F, Jafari Rouhi A, Alavian SM. Intravenous hypnotic regimens in patients with liver disease; a review article. Anesth Pain Med. 2015;5(1):e35333. doi: 10.5812/aapm.23923.
    1. Isitemiz I, Uzman S, Toptas M, Vahapoglu A, Gul YG, Inal FY, et al. Prevention of etomidate-induced myoclonus: which is superior: Fentanyl, midazolam, or a combination? A Retrospective comparative study. Med Sci Monit. 2014;20:262–7. doi: 10.12659/MSM.889833.
    1. Safavi M, Honarmand A, Sahaf AS, Sahaf SM, Attari M, Payandeh M, et al. Magnesium sulfate versus Lidocaine pretreatment for prevention of pain on etomidate injection: A randomized, double-blinded placebo controlled trial. J Res Pharm Pract. 2015;4(1):4–8. doi: 10.4103/2279-042X.150044.
    1. Ko BJ, Oh JN, Lee JH, Choi SR, Lee SC, Chung CJ. Comparison of effects of fentanyl and remifentanil on hemodynamic response to endotracheal intubation and myoclonus in elderly patients with etomidate induction. Korean J Anesthesiol. 2013;64(1):12–8. doi: 10.4097/kjae.2013.64.1.12.
    1. Vuyk JSE, Reekers M. Miller's anesthesia. Philadelphia: Churchill Livingstone; 2015.
    1. Factor S, Lang A, Weiner W. Drug induced movement disorders. John Wiley & Sons; 2008.
    1. He L, Ding Y, Chen H, Qian Y, Li Z. Butorphanol pre-treatment prevents myoclonus induced by etomidate: a randomised, double-blind, controlled clinical trial. Swiss Med Wkly. 2014;144:w14042. doi: 10.4414/smw.2014.14042.
    1. Bruder EA, Ball IM, Ridi S, Pickett W, Hohl C. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev. 2015;1:CD010225. doi: 10.1002/14651858.CD010225.pub2.
    1. Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P. Reducing myoclonus after etomidate. Anesthesiology. 1999;90(1):113–9.
    1. Faught E. Clinical presentations and phenomenology of myoclonus. Epilepsia. 2003;44 Suppl 11:7–12.
    1. Caviness JN. Myoclonus. Mayo Clinic Proceedings; 1996.
    1. Yılmaz Cakirgoz M, Demirel I, Duran E, Ozer AB, Hancı V, Türkmen UA, et al. Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study. Braz J Anesthesiol. 2015 doi: 10.1016/j.bjane.2014.11.014.
    1. Do SH, Han SH, Park SH, Kim JH, Hwang JY, Son IS, et al. The effect of injection rate on etomidate-induced myoclonus. Korean J Anesthesiol. 2008;55(3):305. doi: 10.4097/kjae.2008.55.3.305.
    1. Lee SW, Gill HJ, Park SC, Kim JY, Kim JH, Lee JY, et al. The effect of remifentanil for reducing myoclonus during induction of anesthesia with etomidate. Korean J Anesthesiol. 2009;57(4):438. doi: 10.4097/kjae.2009.57.4.438.
    1. Nooraei N, Solhpour A, Mohajerani SA. Priming with atracurium efficiently suppresses etomidate-induced myoclonus. Acta Anaesthesiol Taiwan. 2013;51(4):145–8. doi: 10.1016/j.aat.2013.12.005.
    1. Hueter L, Schwarzkopf K, Simon M, Bredle D, Fritz H. Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand. 2003;47(4):482–4.
    1. Sutter R, Ristic A, Ruegg S, Fuhr P. Myoclonus in the critically ill: Diagnosis, management, and clinical impact. Clin Neurophysiol. 2016;127(1):67–80. doi: 10.1016/j.clinph.2015.08.009.
    1. Salim B, Siddiqui SZ, Shamim F, Haider S. Effectiveness of Midazolam in the Prevention of Etomidate Induced Myoclonus. J Anesth Clin Res. 2015;2015
    1. Un B, Ceyhan D, Yelken B. Prevention of etomidate-related myoclonus in anesthetic induction by pretreatment with magnesium. J Res Med Sci. 2011;16(11):1490–4.
    1. Kelsaka E, Karakaya D, Sarihasan B, Baris S. Remifentanil pretreatment reduces myoclonus after etomidate. J Clin Anesth. 2006;18(2):83–6. doi: 10.1016/j.jclinane.2005.05.004.
    1. Ri HS, Shin SW, Kim TK, Baik SW, Yoon JU, Byeon GJ. The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection. Korean J Anesthesiol. 2011;61(2):127–32. doi: 10.4097/kjae.2011.61.2.127.
    1. Zou L, Yuan H, Wang HY, Geng ZY, Xu L, Sun L. [Role of target controlled infusion of remifentanil for the prevention of etomidate induced myoclonus during general anesthesia]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013;35(1):112–5.
    1. Schwarzkopf KR, Hueter L, Simon M, Fritz HG. Midazolam pretreatment reduces etomidate-induced myoclonic movements. Anaesth Intensive Care. 2003;31(1):18–20.
    1. Wasinwong W, Uakritdathikar T, Kovitwanawong N, Pakam P. Prevention of Etomidate-Induced Myoclonic Movement After Midazolam Co-Induction with Low-Dose Etomidate. Songklanagarind Med J. 2011;29(1):1–9.
    1. Huter L, Schreiber T, Gugel M, Schwarzkopf K. Low-dose intravenous midazolam reduces etomidate-induced myoclonus: a prospective, randomized study in patients undergoing elective cardioversion. Anesth Analg. 2007;105(5):1298–302. doi: 10.1213/01.ane.0000287248.25610.c0. table of contents.
    1. Gultop F, Akkaya T, Bedirli N, Gumus H. Lidocaine pretreatment reduces the frequency and severity of myoclonus induced by etomidate. J Anesth. 2010;24(2):300–2. doi: 10.1007/s00540-010-0869-6.
    1. Guler A, Satilmis T, Akinci SB, Celebioglu B, Kanbak M. Magnesium sulfate pretreatment reduces myoclonus after etomidate. Anesth Analg. 2005;101(3):705–9. doi: 10.1213/01.ANE.0000160529.95019.E6. table of contents.
    1. Choi JM, Choi IC, Jeong YB, Kim TH, Hahm KD. Pretreatment of rocuronium reduces the frequency and severity of etomidate-induced myoclonus. J Clin Anesth. 2008;20(8):601–4. doi: 10.1016/j.jclinane.2008.06.010.
    1. Mizrak A, Koruk S, Bilgi M, Kocamer B, Erkutlu I, Ganidagli S, et al. Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial. J Surg Res. 2010;159(1):e11–6. doi: 10.1016/j.jss.2009.07.031.
    1. Lv Z, Fang J, Zhu J, Liang B, Li F, Jiang S, et al. Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate. J Anesth. 2014;28(6):944–7. doi: 10.1007/s00540-014-1842-6.
    1. Carlos R, Innerarity S. Effect of premedication on etomidate anaesthesia. Br J Anaesth. 1979;51(12):1159–62.
    1. El Bakry AEA, Marey H. The effect of gabapentin premedication on pain and anxiety during cataract surgery under peribulbar block. Egypt J Anaesth. 2012;28(1):43–7.
    1. Caumo W, Schmidt AP, Schneider CN, Bergmann J, Iwamoto CW, Bandeira D, et al. Risk factors for preoperative anxiety in adults. Acta Anaesthesiol Scand. 2001;45(3):298–307.
    1. Reddy RV, Moorthy SS, Dierdorf SF, Deitch RJ, Link L. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg. 1993;77(5):1008–11.
    1. Hwang JY, Kim JH, Oh AY, Do SH, Jeon YT, Han SH. A comparison of midazolam with remifentanil for the prevention of myoclonic movements following etomidate injection. J Int Med Res. 2008;36(1):17–22.
    1. Vuyk J, Reekers M. Intravenous anesthetics. In: Ronald D, editor. Miller's anesthesia. Philadelphia: Churchill Livingstone; 2015. pp. 842–3.
    1. Korttila K, Tammisto T, Aromaa U. Comparison of etomidate in combination with fentanyl or diazepam, with thiopentone as an induction agent for general anaesthesia. Br J Anaesth. 1979;51(12):1151–7.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren